Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

doi:10.1007/s10585-021-10083-1

. 2021 Jun;38(3):257-261.

doi: 10.1007/s10585-021-10083-1. Epub 2021 Mar 23.

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

P Ivanyi^{1

2

3}, T Park-Simon^{4

5}, H Christiansen^{6

5}, R Gutzmer^{7

5

8}, A Vogel^{9

5}, M Heuser^{10

5}, H Golpon^{11

5}, P Hillemanns^{4

5}, J Haier⁵

Affiliations

¹ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 6860, Carl-Neuberg Strasse 1, 30625, Hannover, OE, Germany. Ivanyi.philipp@mh-hannover.de.
² Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany. Ivanyi.philipp@mh-hannover.de.
³ Immuncooperative Oncology Group (ICOG) of CCC-N, Hannover Medical School, Hannover, Germany. Ivanyi.philipp@mh-hannover.de.
⁴ Department of Gynecology and Obsterics, Hannover Medical School, Hannover, Germany.
⁵ Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany.
⁶ Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany.
⁷ Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.
⁸ Immuncooperative Oncology Group (ICOG) of CCC-N, Hannover Medical School, Hannover, Germany.
⁹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
¹⁰ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 6860, Carl-Neuberg Strasse 1, 30625, Hannover, OE, Germany.
¹¹ Department of Pulmonology, Medizinische Hochschule Hannover, Hannover Medical School, Hannover, Germany.

PMID: 33759009
PMCID: PMC7987238
DOI: 10.1007/s10585-021-10083-1

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

P Ivanyi et al. Clin Exp Metastasis. 2021 Jun.

. 2021 Jun;38(3):257-261.

doi: 10.1007/s10585-021-10083-1. Epub 2021 Mar 23.

Authors

P Ivanyi^{1

2

3}, T Park-Simon^{4

5}, H Christiansen^{6

5}, R Gutzmer^{7

5

8}, A Vogel^{9

5}, M Heuser^{10

5}, H Golpon^{11

5}, P Hillemanns^{4

5}, J Haier⁵

Affiliations

¹ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 6860, Carl-Neuberg Strasse 1, 30625, Hannover, OE, Germany. Ivanyi.philipp@mh-hannover.de.
² Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany. Ivanyi.philipp@mh-hannover.de.
³ Immuncooperative Oncology Group (ICOG) of CCC-N, Hannover Medical School, Hannover, Germany. Ivanyi.philipp@mh-hannover.de.
⁴ Department of Gynecology and Obsterics, Hannover Medical School, Hannover, Germany.
⁵ Comprehensive Cancer Center Niedersachsen (CCC-N), Hannover Medical School, Hannover, Germany.
⁶ Department of Radiotherapy and Special Oncology, Hannover Medical School, Hannover, Germany.
⁷ Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany.
⁸ Immuncooperative Oncology Group (ICOG) of CCC-N, Hannover Medical School, Hannover, Germany.
⁹ Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
¹⁰ Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, 6860, Carl-Neuberg Strasse 1, 30625, Hannover, OE, Germany.
¹¹ Department of Pulmonology, Medizinische Hochschule Hannover, Hannover Medical School, Hannover, Germany.

PMID: 33759009
PMCID: PMC7987238
DOI: 10.1007/s10585-021-10083-1

Abstract

Cancer patients represent a vulnerable cohort during the Sars-CoV-2 pandemic. Oncological societies have generated a plethora of recommendations, but precise instructions about routine oncological procedures remain scarce. Here, we report on local COVID-19 protection measures established in an interdisciplinary approach at a tertiary care center during the first wave of the pandemia in Germany. Following these measures, no additional morbidity or mortality during oncological procedures was observed, and no nosocomial infections were registered. However, Validation of our measures is outstanding and regional SARS-CoV-2 prevalence was low. However, specific oncological measures might be important to ensure optimal oncological results, especially for advanced cancer stages during this and future pandemia. In the future, communication about these measures might be crucial to a cancer patient´s assigned network to reduce the danger of excess mortality within the second wave of the COVID-19 pandemic.

Keywords: COVID-19; Cancer; Metastasis; Sars-CoV-19; Treatment.

PubMed Disclaimer

Figures

**Fig. 1**
Pandemic-adapted oncological consideration algorithm for advanced disease status

See this image and copyright information in PMC

Cited by

Impact of COVID-19 on Head and Neck Cancer Advancement Measured by Increasing Numbers of Urgent Dyspnea Cases-What Could Be Improved in the Event of Subsequent Pandemics?
Pietruszewska W, Burduk P, Rosiak O, Podlawska P, Zakrzewski B, Barańska M, Kowalczyk M, Piątkowski J, Śmigielski G, Solarz P, Staszak M, Wierzbicka M, Mikaszewski B. Pietruszewska W, et al. J Clin Med. 2022 Oct 28;11(21):6385. doi: 10.3390/jcm11216385. J Clin Med. 2022. PMID: 36362613 Free PMC article.
Trust in Healthcare during COVID-19 in Europe: vulnerable groups trust the least.
Beller J, Schäfers J, Haier J, Geyer S, Epping J. Beller J, et al. Z Gesundh Wiss. 2022 Mar 24:1-10. doi: 10.1007/s10389-022-01705-3. Online ahead of print. Z Gesundh Wiss. 2022. PMID: 35345647 Free PMC article.
Decision Conflicts in Clinical Care during COVID-19: A Patient Perspective.
Haier J, Beller J, Adorjan K, Bleich S, De Greck M, Griesinger F, Hein A, Hurlemann R, Mees ST, Philipsen A, Rohde G, Schilling G, Trautmann K, Combs SE, Geyer S, Schäfers J. Haier J, et al. Healthcare (Basel). 2022 May 31;10(6):1019. doi: 10.3390/healthcare10061019. Healthcare (Basel). 2022. PMID: 35742070 Free PMC article.
A pyramid model to describe changing decision making under high uncertainty during the COVID-19 pandemic.
Haier J, Mayer M, Schaefers J, Geyer S, Feldner D. Haier J, et al. BMJ Glob Health. 2022 Aug;7(8):e008854. doi: 10.1136/bmjgh-2022-008854. BMJ Glob Health. 2022. PMID: 35940628 Free PMC article. Review.
Combination Chemotherapy with Selected Polyphenols in Preclinical and Clinical Studies-An Update Overview.
Jakobušić Brala C, Karković Marković A, Kugić A, Torić J, Barbarić M. Jakobušić Brala C, et al. Molecules. 2023 Apr 26;28(9):3746. doi: 10.3390/molecules28093746. Molecules. 2023. PMID: 37175156 Free PMC article.

References

1. Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17:268–270. doi: 10.1038/s41571-020-0362-6. - DOI - PMC - PubMed
1. Harky A, Chiu CM, Yau THL, Lai SHD. Cancer Patient Care during COVID-19. Cancer Cell. 2020;37:749–750. doi: 10.1016/j.ccell.2020.05.006. - DOI - PMC - PubMed
1. Lai A, Pasea L, Banerjee A, et al (2020) Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. Doi: 10.1101/2020.05.27.20083287
1. Jones D, Neal RD, Duffy SRG, et al. Comment Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer : the view from primary care. Lancet Oncol. 2020;2045:19–20. doi: 10.1016/S1470-2045(20)30242-4. - DOI - PMC - PubMed
1. Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17:336. doi: 10.1038/s41571-020-0366-2. - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

[1] Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17:268–270. doi: 10.1038/s41571-020-0362-6. - DOI - PMC - PubMed

[2] Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17:268–270. doi: 10.1038/s41571-020-0362-6. - DOI - PMC - PubMed

[3] Harky A, Chiu CM, Yau THL, Lai SHD. Cancer Patient Care during COVID-19. Cancer Cell. 2020;37:749–750. doi: 10.1016/j.ccell.2020.05.006. - DOI - PMC - PubMed

[4] Harky A, Chiu CM, Yau THL, Lai SHD. Cancer Patient Care during COVID-19. Cancer Cell. 2020;37:749–750. doi: 10.1016/j.ccell.2020.05.006. - DOI - PMC - PubMed

[5] Lai A, Pasea L, Banerjee A, et al (2020) Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. Doi: 10.1101/2020.05.27.20083287

[6] Lai A, Pasea L, Banerjee A, et al (2020) Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency. Doi: 10.1101/2020.05.27.20083287

[7] Jones D, Neal RD, Duffy SRG, et al. Comment Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer : the view from primary care. Lancet Oncol. 2020;2045:19–20. doi: 10.1016/S1470-2045(20)30242-4. - DOI - PMC - PubMed

[8] Jones D, Neal RD, Duffy SRG, et al. Comment Impact of the COVID-19 pandemic on the symptomatic diagnosis of cancer : the view from primary care. Lancet Oncol. 2020;2045:19–20. doi: 10.1016/S1470-2045(20)30242-4. - DOI - PMC - PubMed

[9] Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17:336. doi: 10.1038/s41571-020-0366-2. - DOI - PMC - PubMed

[10] Sidaway P. COVID-19 and cancer: what we know so far. Nat Rev Clin Oncol. 2020;17:336. doi: 10.1038/s41571-020-0366-2. - DOI - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Affiliations

Protective measures for patients with advanced cancer during the Sars-CoV-2 pandemic: Quo vadis?

Authors

Affiliations

Abstract

Figures

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous